Non-Surgical Weight Loss in St. Louis
St. Alexius NewStart is proud to be among the first bariatric surgery centers in the St. Louis area to offer the ORBERA™ Intragastric Balloon. Our bariatric surgeons are trained experts in the placement and management of ORBERA™, and are excited to offer yet another option to help you achieve your long-term weight-loss goals.
Learning more about our non-surgical ORBERA™ procedure begins here. Watch this short video to better understand the ORBERA™option.
What is ORBERA™?
ORBERA™ is an incision-less, non-surgical solution for those patients who are not eligible for or interested in undergoing invasive surgery, as well as those patients who, in many cases, have not found success through diet and exercise or pharmaceutical interventions.
ORBERA™ is intended for patients with a Body Mass Index (BMI) of 30 to 40 who have already attempted traditional weight reduction alternatives. The balloon is part of the ORBERA™ Managed Weight Loss System—a comprehensive, non-surgical two-part program that begins with the placement of a space-filling, durable balloon in a patient’s stomach to reinforce proper portion control.
In a non-surgical procedure, typically performed with the patient under a mild sedative, the thin and deflated ORBERA™ balloon is placed into the stomach. It is then filled with saline until it is about the size of a grapefruit. The procedure normally takes about 20-30 minutes and people can generally go home the same day. Once the balloon is in place, the patient is enrolled in an individually-tailored support program organized by an ORBERA™ Managed Weight Loss System team of experts, which may include a dietitian, psychologist and exercise physiologist. The team helps keep patients motivated, coordinate their programs, and work through weight-loss barriers to meet long-term weight-loss goals.
Once the balloon is in place, the 12-month coaching program begins. At six months, the balloon is removed in the same way it was placed. Through a non-surgical procedure performed with the patient under a mild sedative, it is deflated and then removed.
Data on ORBERA™ collected in the U.S. clinical trial has shown the average person lost 3.1x the weight as compared to diet and exercise alone within a six-month period. ORBERA™ is a safe and effective weight-loss solution with over 220,000 placements worldwide.